SP2 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 1.249730E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
1.704960E-01
Normal-vs-Stage2
6.404600E-03
Normal-vs-Stage3
4.363700E-02
Normal-vs-Stage4
5.851200E-01
Stage1-vs-Stage2
5.060200E-01
Stage1-vs-Stage3
1.099800E-01
Stage1-vs-Stage4
4.362600E-01
Stage2-vs-Stage3
8.287800E-02
Stage2-vs-Stage4
6.902100E-02
Stage3-vs-Stage4
8.076100E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
1.288310E-02
Normal-vs-AfricanAmerican
1.169590E-01
Normal-vs-Asian
5.362400E-02
Caucasian-vs-AfricanAmerican
8.143600E-01
Caucasian-vs-Asian
3.670600E-01
AfricanAmerican-vs-Asian
5.053200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
9.819300E-03
Normal-vs-Female
2.327700E-02
Male-vs-Female
5.036600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
4.314800E-01
Normal-vs-Age(41-60Yrs)
1.064480E-02
Normal-vs-Age(61-80Yrs)
1.777890E-02
Normal-vs-Age(81-100Yrs)
2.017600E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
6.511000E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
4.151800E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
5.383200E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
3.302000E-02
Age(41-60Yrs)-vs-Age(81-100Yrs)
9.344000E-02
Age(61-80Yrs)-vs-Age(81-100Yrs)
6.922400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
9.742000E-03
Normal-vs-Daily Drinker
2.876800E-03
Normal-vs-Weekly Drinker
4.978300E-02
Normal-vs-Occasional Drinker
1.289970E-01
Normal-vs-Social Drinker
7.643900E-02
Non Drinker-vs-Daily Drinker
9.672200E-01
Non Drinker-vs-Weekly Drinker
5.699600E-01
Non Drinker-vs-Occasional Drinker
4.752200E-02
Non Drinker-vs-Social Drinker
1.787000E-01
Daily Drinker-vs-Weekly Drinker
5.168400E-01
Daily Drinker-vs-Occasional Drinker
3.462000E-02
Daily Drinker-vs-Social Drinker
1.362970E-01
Weekly Drinker-vs-Occasional Drinker
2.634600E-01
Weekly Drinker-vs-Social Drinker
5.327800E-01
Occasional Drinker-vs-Social Drinker
6.071200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
1.443760E-01
Normal-vs-Grade 2
2.250400E-02
Normal-vs-Grade 3
4.857400E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
8.203400E-01
Grade 1-vs-Grade 3
5.321400E-01
Grade 1-vs-Grade 4
1.443760E-01
Grade 2-vs-Grade 3
4.546800E-01
Grade 2-vs-Grade 4
2.250400E-02
Grade 3-vs-Grade 4
4.857400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
1.818230E-02
Normal-vs-NonDiabetic
1.120060E-02
Diabetic-vs-NonDiabetic
4.565800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
1.767990E-01
Normal-vs-NoPancreatitis
1.449770E-02
Pancreatitis-vs-NoPancreatitis
2.648400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
3.391700E-02
Normal-vs-N1
8.357200E-03
N0-vs-N1
4.772000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
2.938400E-01
Normal-vs-TP53-NonMutant
1.143360E-01
TP53-Mutant-vs-TP53-NonMutant
4.379800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
